COGT

Cogent Biosciences Stock Analysis

AI Rating

Low
  • Quality0/10
  • Growth↓ 0/10
  • Value↑ 6/10
Cogent Biosciences sales and earnings growth
COGT Growth
Low
  • Revenue Y/Y↓ 0.00%
  • EPS Y/Y↓ -10.15%
  • FCF Y/Y↓ -28.48%
Cogent Biosciences gross and profit margin trends
COGT Profitability
Low
  • Gross margin ↓ 0.00%
  • EPS margin↓ 0.00%
  • ROIC 5Y↓ -106.35%
Cogent Biosciences net debt vs free cash flow
COGT Risk
Great
  • Debt / Equity↓ 0.4
  • Debt / FCF↓ 0.0
  • Interest coverage↓ -81.9

Cogent Biosciences stock volatility is higher than the overall market. We give it a Great risk rating.

↗ More Biotechnology stocks